Kuwano A, Yada M, Tanaka K, Hamamoto T, et al. Pretreatment Tumor-infiltrating CD8(+) T Cell Numbers Are Associated With the Response to Tremelimumab Plus Durvalumab in Hepatocellular Carcinoma. Anticancer Res 2026;46:4077-4085.
PMID: 42373240